Gene Therapy Pipeline

About Bedrock Therapeutics

Bedrock Therapeutics is a private, pre-clinical stage biotech developing next-generation AAV-based gene therapies. Its core technology platform centers on engineering human-tropic and antibody-evading AAV capsids to improve targeting and overcome immune responses, alongside developing single-chain immune modulators (scIMs). The company's initial pipeline is focused on ophthalmic conditions, aiming to deliver safe, single-dose therapeutics. Led by a team of scientific co-founders and experienced executives, Bedrock is positioned to address key limitations in current gene therapy delivery and efficacy.

Therapeutic Areas

Other Ophthalmic Diseases (unspecified) Drugs